Bordeaux, France
  15-17 October, 2018

Organ-on-chip (OoC) technology is providing new platforms for drug discovery and toxicity testing and has the potential to become powerful for disease modelling and personalised medicine. This course will cover ongoing efforts and various applications of OoC while also addressing ethical issues.

ORGANIZERS: Nathalie PICOLLET D’HAHAN (CEA-BGE-Biomics, Grenoble), Donald K. MARTIN (TIMC-

IMAG, UGA, Grenoble), Christophe MARQUETTE (ICBMS-Université Lyon1-CNRS, Villeurbanne).

Organ-on-chip (OOC) technology is providing new platforms for drug discovery and toxicity testing and has the potential to become powerful for disease modelling and personalised medicine. This course will cover ongoing efforts and various applications of OOC while also addressing ethical issues.

Registrationateliers@inserm.fr

REGISTRATION DEADLINE: June 29, 2018
see also: phase II workshop

ORGANIZERS: Nathalie PICOLLET D’HAHAN (CEA-BGE-Biomics, Grenoble), Donald K. MARTIN (TIMC-

IMAG, UGA, Grenoble), Christophe MARQUETTE (ICBMS-Université Lyon1-CNRS, Villeurbanne).

Organ-on-chip (OOC) technology is providing new platforms for drug discovery and toxicity testing and has the potential to become powerful for disease modelling and personalised medicine. This course will cover ongoing efforts and various applications of OOC while also addressing ethical issues.

Registrationateliers@inserm.fr

REGISTRATION DEADLINE: June 29, 2018
see also: phase II workshop

 

Share This